128 related articles for article (PubMed ID: 8783159)
1. A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs.
Yoshida M; Yamada M; Chatterjee S; Lakeman F; Nii S; Whitley RJ
J Virol Methods; 1996 Apr; 58(1-2):137-43. PubMed ID: 8783159
[TBL] [Abstract][Full Text] [Related]
2. Comparison of antiviral compounds against human herpesvirus 6 and 7.
Yoshida M; Yamada M; Tsukazaki T; Chatterjee S; Lakeman FD; Nii S; Whitley RJ
Antiviral Res; 1998 Dec; 40(1-2):73-84. PubMed ID: 9864048
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of human herpesvirus 6 to antiviral compounds by flow cytometry analysis.
Manichanh C; Grenot P; Gautheret-Dejean A; Debré P; Huraux JM; Agut H
Cytometry; 2000 Jun; 40(2):135-40. PubMed ID: 10805933
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6.
Reymen D; Naesens L; Balzarini J; Holý A; Dvoráková H; De Clercq E
Antiviral Res; 1995 Dec; 28(4):343-57. PubMed ID: 8669893
[TBL] [Abstract][Full Text] [Related]
5. Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
Long MC; Bidanset DJ; Williams SL; Kushner NL; Kern ER
Antiviral Res; 2003 Apr; 58(2):149-57. PubMed ID: 12742575
[TBL] [Abstract][Full Text] [Related]
6. [Recent advances in antiviral drugs--antiviral agents to HCMV, HHV-6, and HHV-7].
Takahashi K
Nihon Rinsho; 1998 Jan; 56(1):140-4. PubMed ID: 9465679
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
Amjad M; Gillespie MA; Carlson RM; Karim MR
Microbiol Immunol; 2001; 45(3):233-40. PubMed ID: 11345533
[TBL] [Abstract][Full Text] [Related]
8. A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents.
Gangopadhyay NN; Whitley RJ; Chatterjee S
J Virol Methods; 1994 Jul; 48(2-3):273-9. PubMed ID: 7527404
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of human cytomegalovirus DNA synthesis by (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine [(S)-HPMPC] and 9-(1,3-dihydroxy-2-propoxymethyl)guanine (DHPG).
Neyts J; Snoeck R; Schols D; Balzarini J; De Clercq E
Virology; 1990 Nov; 179(1):41-50. PubMed ID: 2171213
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
Smee DF; Barnett BB; Sidwell RW; Reist EJ; Holy A
Antiviral Res; 1995 Jan; 26(1):1-9. PubMed ID: 7741517
[TBL] [Abstract][Full Text] [Related]
11. Immunotoxic potential of antiviral drugs: effects of ganciclovir and (S)-1-(3-hydroxy-2-phosphonylmethoxy propyl) cytosine on lymphocyte transformation and delayed-type hypersensitivity responses.
Simecka JW; Patel P; Kern ER
Antiviral Res; 1992 May; 18(1):53-64. PubMed ID: 1416903
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of susceptibility of human herpesvirus 8 to antiviral drugs by quantitative real-time PCR.
Sergerie Y; Boivin G
J Clin Microbiol; 2003 Aug; 41(8):3897-900. PubMed ID: 12904413
[TBL] [Abstract][Full Text] [Related]
13. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
Medveczky MM; Horvath E; Lund T; Medveczky PG
AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antiviral activity of the nucleotide analogue (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cytosine.
Bronson JJ; Ghazzouli I; Hitchcock MJ; Webb RR; Martin JC
J Med Chem; 1989 Jul; 32(7):1457-63. PubMed ID: 2544723
[TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
Maggs DJ; Clarke HE
Am J Vet Res; 2004 Apr; 65(4):399-403. PubMed ID: 15077679
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the catalytic subunit of the human herpesvirus 6 (HHV-6) DNA polymerase expressed in an in vitro transcription/translation assay.
De Bolle L; Balzarini J; De Clercq E; Naesens L
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):999-1001. PubMed ID: 14565330
[No Abstract] [Full Text] [Related]
17. Antiviral drug susceptibility of human herpesvirus 8.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1997 Dec; 41(12):2754-6. PubMed ID: 9420052
[TBL] [Abstract][Full Text] [Related]
18. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.
Neyts J; Snoeck R; Balzarini J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):41-52. PubMed ID: 1663729
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of antiviral activity against human herpesvirus 8 (HHV-8) and Epstein-Barr virus (EBV) by a quantitative real-time PCR assay.
Friedrichs C; Neyts J; Gaspar G; De Clercq E; Wutzler P
Antiviral Res; 2004 Jun; 62(3):121-3. PubMed ID: 15130535
[TBL] [Abstract][Full Text] [Related]
20. Comparative activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine against rat cytomegalovirus infection in vitro and in vivo.
Stals FS; de Clercq E; Bruggeman CA
Antimicrob Agents Chemother; 1991 Nov; 35(11):2262-6. PubMed ID: 1666493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]